EndoStim Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
EndoStim General Information
Description
Developer of an implantable neurostimulation device designed to treat gastroesophageal reflux disease through electrical stimulation of the lower esophageal sphincter. The company offers a first-in-class implantable system that automatically delivers mild electrical signals throughout the day to the lower esophageal sphincter muscle, restoring function to the weakened valve between the esophagus and stomach without relying on pharmaceutical intervention, enabling patients to reduce or avoid typical gastrointestinal side effects of traditional anti-reflux surgery.
Contact Information
Website
www.endostim.comCorporate Office
- 4101 McEwen
- Suite 336
- Dallas, TX 75244
- United States
Corporate Office
- 4101 McEwen
- Suite 336
- Dallas, TX 75244
- United States
EndoStim Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 01-Dec-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 01-Aug-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 12-Jan-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 01-Mar-2016 | Completed | Generating Revenue | |||
| 6. IPO | 09-Dec-2015 | Cancelled | Generating Revenue | |||
| 5. Later Stage VC (Series C1) | 01-May-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 29-May-2013 | Completed | Startup | |||
| 3. Early Stage VC (Series B1) | 01-Nov-2011 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 13-Jul-2010 | $6M | $7.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 30-Sep-2009 | $1.5M | $1.5M | Completed | Startup |
EndoStim Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D3 | ||||||||
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series D | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | 1,119,317 | $0.001000 | 8% | $5 | $5 | $3.13 | 5.96% | |
| Series A | 195,452 | $0.001000 | 8% | $3.33 | $3.33 | $2.63 | 0.82% |
EndoStim Comparisons
Industry
Financing
Details
EndoStim Competitors (12)
One of EndoStim’s 12 competitors is Insightec, a Venture Capital-Backed company based in Tirat Carmel, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Insightec | Venture Capital-Backed | Tirat Carmel, Israel | ||||
| Spatz (Therapeutic Devices) | Venture Capital-Backed | Fort Lauderdale, FL | ||||
| Morphic Medical | Private Equity-Backed | Boston, MA | ||||
| EndoGastric Solutions | Formerly VC-backed | Redmond, WA | ||||
| USGI Medical | Venture Capital-Backed | San Clemente, CA |
EndoStim Patents
EndoStim Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026232042-A1 | Hiatal hernia procedure combined with an implanted electrical stimulation system to treat gastroesophageal reflux disease | Pending | 01-May-2025 | ||
| US-12465761-B2 | Electrical stimulation system for the treatment of gastrointestinal disorders | Active | 06-Feb-2018 | ||
| US-20260131141-A1 | Electrical stimulation system for the treatment of gastrointestinal disorders | Pending | 06-Feb-2018 | ||
| EP-3606603-A1 | Implantable surface electrodes and method of implantation | Inactive | 06-Apr-2017 | ||
| US-20190105491-A1 | Implantable surface electrodes and method of implantation | Active | 06-Apr-2017 | A61N1/0517 |
EndoStim Signals
EndoStim Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Integer Holdings | PE-Backed Company | Minority | ||
| Stifel Financial | Investment Bank | Minority |
EndoStim FAQs
-
When was EndoStim founded?
EndoStim was founded in 2009.
-
Where is EndoStim headquartered?
EndoStim is headquartered in Dallas, TX.
-
What is the size of EndoStim?
EndoStim has 4 total employees.
-
What industry is EndoStim in?
EndoStim’s primary industry is Therapeutic Devices.
-
Is EndoStim a private or public company?
EndoStim is a Private company.
-
What is EndoStim’s current revenue?
The current revenue for EndoStim is .
-
How much funding has EndoStim raised over time?
EndoStim has raised $73.5M.
-
Who are EndoStim’s investors?
Integer Holdings and Stifel Financial have invested in EndoStim.
-
Who are EndoStim’s competitors?
Insightec, Spatz (Therapeutic Devices), Morphic Medical, EndoGastric Solutions, and USGI Medical are some of the 12 competitors of EndoStim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process